Phenixfin Market Cap from 2010 to 2026

PFX Stock  USD 41.63  -0.37  -0.88%   
Over recent reporting cycles, Market Cap is dropping amid slightly volatile fluctuations. Compared with the previous period, Market Cap is down roughly 5.26%, indicating near-term softness. From 2010 to 2026, the annual regression model for Phenixfin Market Cap reported a slope of -77,178,467 . with r-squared of 0.58 . View All Fundamentals
 
Market Cap  
 First Reported
2010-12-31
 Previous Quarter
111.7 M
 Current Value
106.1 M
 Quarterly Volatility
510.9 M
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Review Phenixfin financial statements over time to add context on performance and capital structure. It connects Interest Expense of 11.8 M, Total Revenue of 11.4 M or Gross Profit of 11.1 M and ratios such as Price To Sales Ratio of 7.86, Dividend Yield of 0.036 or PTB Ratio of 7.0E-4 with Phenixfin Valuation and Volatility context.
  
Build AI portfolio with Phenixfin Stock
Review Phenixfin Correlation against competitors for Phenixfin. This provides competitive positioning context.
To learn how to invest in Phenixfin Stock, please use our How to Invest in Phenixfin guide.
Analyzing Phenixfin's Market Cap over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Market Cap has evolved provides context for assessing Phenixfin's current valuation and future prospects.

Latest Phenixfin's Market Cap Growth Pattern

Below is the plot of the Market Cap of Phenixfin over the last few years. It is Phenixfin's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Phenixfin's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

Phenixfin Market Cap Regression Statistics

Arithmetic Mean 540,432,392
Geometric Mean 312,410,626
Coefficient Of Variation 94.53
Mean Deviation 433,049,483
Median 402,019,448
Standard Deviation 510,873,929
Sample Variance260992.2T
Range1.5B
R-Value-0.76
Mean Square Error116374.4T
R-Squared 0.58
Significance 0.0004
Slope-77,178,467
Total Sum of Squares4175874.7T

Phenixfin Market Cap History

2026106.1 M
2025111.7 M
202397.1 M
202279.3 M
202181 M
2020114.9 M
2019138.4 M

Stock Overview, Methodology & Data Sources

The firm seeks to invest in privately negotiated debt and equity securities of small and middle market companies. PhenixFIN Corporation was founded in 2010 and is headquartered in New York, New York. Phenixfin Corp operates under Asset Management classification in the United States and is traded on NASDAQ Exchange. It employs 7 people. The profile for Phenixfin integrates fundamentals, price behavior, and sector exposure. Historical patterns suggest somewhat reduced sensitivity to broader economic swings. Phenixfin has a market cap of 83.92 M, P/E of 71.8, ROE of -1.93%.

Methodology

Unless otherwise specified, financial data for Phenixfin is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Phenixfin (USA Stocks:PFX) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for Phenixfin is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR. Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Phenixfin may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

More Resources for Phenixfin Stock Analysis

A structured review of Phenixfin often starts with core financial statements and trend context. Ratios and trend metrics help frame Phenixfin's operating context. Key reports that frame Phenixfin Stock are listed below:
Review Phenixfin Correlation against competitors for Phenixfin. This provides competitive positioning context.
To learn how to invest in Phenixfin Stock, please use our How to Invest in Phenixfin guide.
Analysis related to Phenixfin should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
 Quarterly Earnings Growth
-0.33
 Earnings Share
-1.54
 Revenue Per Share
12.785
 Quarterly Revenue Growth
0.071
 Return On Assets
0.0319
The market value of Phenixfin is measured differently than book value, which reflects Phenixfin accounting equity. Phenixfin's market capitalization is 83.92 M. A P/B ratio of 0.53 suggests Phenixfin trades near or below book value. Enterprise value stands at 229.54 M. Value and price for Phenixfin are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that Phenixfin's intrinsic value and market price are different measures derived from different inputs. For Phenixfin, key inputs include a P/E ratio of 71.8, a P/B ratio of 0.53, a profit margin of -11.98%, and ROE of -1.93%. Market price reflects the current exchange level formed by active bids and offers.